BioNTech SEBioNTech SEBioNTech SE

BioNTech SE

No trades
See on Supercharts

BNTX fundamentals

An in-depth look to BioNTech SE operating, investing, and financing activities

BNTX free cash flow for Q4 23 is 1.14 B USD. For 2023, BNTX free cash flow was 5.54 B USD and operating cash flow was 5.81 B USD.

Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
‪0.00‬
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
TTM
Free cash flowYoY growth